The United States Pharmacopeia Convention finalized revisions to the U.S. Pharmacopeia 797 guidelines. Knowledge of these changes in the standardization process for the preparation of sterile compounded drugs are essential for pharmacist, pharmacy technicians and nurses who are involved with any aspect of the compounding process. The purpose of this knowledge-based activity is to review regulatory requirements surrounding sterile drug preparation. Hospital administration and support departments should have a basic understanding of the regulatory requirements to support compliance.
Who Should Attend?
CEOs, CFOs, COOs, directors of pharmacy, nursing, compliance, housekeeping, regulation and accreditation